FDA Drug Application (090541) for TRI-LO-LINYAH by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number090541
Product Number001
FormTABLET; ORAL
Dosage0.18MG; 0.025MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTRI-LO-LINYAH
Active IngredientNORGESTIMATE; ETHINYL ESTRADIOL

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORGESTIMATE23


Back to FDA Applications sponsored by NOVAST LABS LTD